Renaissance Technologies LLC, under direction of Jim Simons has filed its 13F form on November 13, 2024 for Q3 2024 where it was disclosed a total value porftolio of $63.1 Billion distributed in 3484 stocks.
Among their holdings, we can observe that their the top five positions include companies like: Palantir Technologies Inc. with a value of $1.43B, Novo Nordisk A S with a value of $975M, United Therapeutics Corp with a value of $772M, Apple Inc. with a value of $763M, and Vertex Pharmaceuticals Inc with a value of $759M.
Examining the 13F form we can see an increase of $6.45B in the current position value, from $56.7B to 63.1B.
Renaissance Technologies LLC is based out at New York, NY
Below you can find more details about Jim Simons portfolio as well as his latest detailed transactions.
Jim Simons is the founder and chairman of Renaissance Technologies, a successful investment firm that uses quantitative approaches to investing. Simons is known for his expertise in mathematical modeling and has a reputation for being a skilled and successful investor. He has generated strong returns for his clients over the long term.
